APA (7th ed.) Citation

Takuma Yonemura, Rie Yazawa, Miwa Haranaka, Kazuki Kawakami, Masayuki Takanuma, Takumi Kanzo, . . . Yasumasa Arai. (2022). Comparison of two biosimilarity studies of FKB327 with the adalimumab reference product: Randomized phase 1 studies of single-blind, single-dose subcutaneous injection in healthy Japanese male participants. BMC.

Chicago Style (17th ed.) Citation

Takuma Yonemura, Rie Yazawa, Miwa Haranaka, Kazuki Kawakami, Masayuki Takanuma, Takumi Kanzo, Dimitris Stefanidis, and Yasumasa Arai. Comparison of Two Biosimilarity Studies of FKB327 with the Adalimumab Reference Product: Randomized Phase 1 Studies of Single-blind, Single-dose Subcutaneous Injection in Healthy Japanese Male Participants. BMC, 2022.

MLA (9th ed.) Citation

Takuma Yonemura, et al. Comparison of Two Biosimilarity Studies of FKB327 with the Adalimumab Reference Product: Randomized Phase 1 Studies of Single-blind, Single-dose Subcutaneous Injection in Healthy Japanese Male Participants. BMC, 2022.